408 related articles for article (PubMed ID: 30030006)
1. Human T
Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
[TBL] [Abstract][Full Text] [Related]
3. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
4. STAT1 and STAT3 mutations: important lessons for clinical immunologists.
Olbrich P; Freeman AF
Expert Rev Clin Immunol; 2018 Dec; 14(12):1029-1041. PubMed ID: 30280610
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
6. IL-4 confers resistance to IL-27-mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling.
Chen Z; Wang S; Erekosima N; Li Y; Hong J; Qi X; Merkel P; Nagabhushanam V; Choo E; Katial R; Alam R; Trikha A; Chu HW; Zhuang Y; Jin M; Bai C; Huang H
J Allergy Clin Immunol; 2013 Oct; 132(4):912-21.e1-5. PubMed ID: 23958647
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Assessment of STAT Molecules in Th9 Cells.
Garo LP; Beynon V; Murugaiyan G
Methods Mol Biol; 2017; 1585():127-140. PubMed ID: 28477192
[TBL] [Abstract][Full Text] [Related]
8. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3.
Wang H; Meng R; Li Z; Yang B; Liu Y; Huang F; Zhang J; Chen H; Wu C
Immunol Lett; 2011 Apr; 136(1):21-8. PubMed ID: 21115047
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
[TBL] [Abstract][Full Text] [Related]
10. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies.
Ma CS; Wong N; Rao G; Avery DT; Torpy J; Hambridge T; Bustamante J; Okada S; Stoddard JL; Deenick EK; Pelham SJ; Payne K; Boisson-Dupuis S; Puel A; Kobayashi M; Arkwright PD; Kilic SS; El Baghdadi J; Nonoyama S; Minegishi Y; Mahdaviani SA; Mansouri D; Bousfiha A; Blincoe AK; French MA; Hsu P; Campbell DE; Stormon MO; Wong M; Adelstein S; Smart JM; Fulcher DA; Cook MC; Phan TG; Stepensky P; Boztug K; Kansu A; İkincioğullari A; Baumann U; Beier R; Roscioli T; Ziegler JB; Gray P; Picard C; Grimbacher B; Warnatz K; Holland SM; Casanova JL; Uzel G; Tangye SG
J Allergy Clin Immunol; 2015 Oct; 136(4):993-1006.e1. PubMed ID: 26162572
[TBL] [Abstract][Full Text] [Related]
11. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.
Avery DT; Deenick EK; Ma CS; Suryani S; Simpson N; Chew GY; Chan TD; Palendira U; Bustamante J; Boisson-Dupuis S; Choo S; Bleasel KE; Peake J; King C; French MA; Engelhard D; Al-Hajjar S; Al-Muhsen S; Magdorf K; Roesler J; Arkwright PD; Hissaria P; Riminton DS; Wong M; Brink R; Fulcher DA; Casanova JL; Cook MC; Tangye SG
J Exp Med; 2010 Jan; 207(1):155-71. PubMed ID: 20048285
[TBL] [Abstract][Full Text] [Related]
12. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.
Wan CK; Andraski AB; Spolski R; Li P; Kazemian M; Oh J; Samsel L; Swanson PA; McGavern DB; Sampaio EP; Freeman AF; Milner JD; Holland SM; Leonard WJ
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9394-9. PubMed ID: 26170288
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27.
Murugaiyan G; Beynon V; Pires Da Cunha A; Joller N; Weiner HL
J Immunol; 2012 Dec; 189(11):5277-83. PubMed ID: 23125412
[TBL] [Abstract][Full Text] [Related]
15. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
[TBL] [Abstract][Full Text] [Related]
16. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
17. Functional STAT3 deficiency compromises the generation of human T follicular helper cells.
Ma CS; Avery DT; Chan A; Batten M; Bustamante J; Boisson-Dupuis S; Arkwright PD; Kreins AY; Averbuch D; Engelhard D; Magdorf K; Kilic SS; Minegishi Y; Nonoyama S; French MA; Choo S; Smart JM; Peake J; Wong M; Gray P; Cook MC; Fulcher DA; Casanova JL; Deenick EK; Tangye SG
Blood; 2012 Apr; 119(17):3997-4008. PubMed ID: 22403255
[TBL] [Abstract][Full Text] [Related]
18. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
19. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
[TBL] [Abstract][Full Text] [Related]
20. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
Front Immunol; 2021; 12():654406. PubMed ID: 33777053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
